Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  1,220 نتائج ل ""glucagon-like peptides""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Association of semaglutide treatment with coronary artery inflammation in type 2 diabetes mellitus patients: a retrospective study based on pericoronary adipose tissue attenuation.

  • Authors : Li Y; Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, China.; Department of Internal Medicine, Graduate School of Hebei Medical University, Shijiazhuang, China.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Sep 28; Vol. 23 (1), pp. 348. Date of Electronic Publication: 2024 Sep 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

تفاصيل العنوان

×
Academic Journal

Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics.

  • Authors : Inokuchi T; Inokuchi Medical Clinic, Fukuoka, Japan.; Department of Auditors, Japan Physicians Association, Tokyo, Japan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2024 Sep; Vol. 15 (9), pp. 1202-1210. Date of Electronic Publication: 2024 May 03.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

تفاصيل العنوان

×
Academic Journal

Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk.

  • Authors : Diab H; School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA.; Fuquay T

Subjects: Milk, Human*/Milk, Human*/Milk, Human*/chemistry ; Breast Feeding* ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage

  • Source: Nutrients [Nutrients] 2024 Aug 28; Vol. 16 (17). Date of Electronic Publication: 2024 Aug 28.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of Semaglutide.

  • Authors : Shapira-Furman T; Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, P.O. Box 12065, Jerusalem 91120, Israel.; Bar-Hai A

Subjects: Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/pharmacokinetics ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/chemistry

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Aug 19; Vol. 29 (16). Date of Electronic Publication: 2024 Aug 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

×
Academic Journal

Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study).

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage

  • Source: Nutrients [Nutrients] 2024 Aug 03; Vol. 16 (15). Date of Electronic Publication: 2024 Aug 03.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan.

  • Authors : Suzuki R; Department of Diabetes, Metabolism, and Endocrinology, Tokyo Medical University, Tokyo, Japan.; Amadid H

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2024 Aug; Vol. 15 (8), pp. 1047-1056. Date of Electronic Publication: 2024 May 06.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

تفاصيل العنوان

×
Academic Journal

Efficacy and safety of oral semaglutide in older patients with type 2 diabetes: a retrospective observational study (the OTARU-SEMA study).

  • Authors : Oe Y; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University Graduate School of Medicine, North-15, West-7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan.; Department of Diabetes, Otaru General Hospital, Wakamatsu-1-1-1, Otaru, Hokkaido, 047-0017, Japan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use

  • Source: BMC endocrine disorders [BMC Endocr Disord] 2024 Jul 24; Vol. 24 (1), pp. 124. Date of Electronic Publication: 2024 Jul 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823

تفاصيل العنوان

×
Academic Journal

The benefits of GLP-1 drugs beyond obesity.

  • Authors : Drucker DJ; The Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, and the Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Subjects: Cardiovascular System*/Cardiovascular System*/Cardiovascular System*/drug effects ; Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/administration & dosage ; Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/pharmacology

  • Source: Science (New York, N.Y.) [Science] 2024 Jul 19; Vol. 385 (6706), pp. 258-260. Date of Electronic Publication: 2024 Jul 18.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic

تفاصيل العنوان

×
  • 1-10 ل  1,220 نتائج ل ""glucagon-like peptides""